Intrinsic Value of S&P & Nasdaq Contact Us

Ares Commercial Real Estate Corporation ACRE NYSE

NYSE • Real Estate • REIT - Mortgage • US • USD

SharesGrow Score
23/100
0/7 Pass
SharesGrow Intrinsic Value
$1.14
-77.9%
Analyst Price Target
$5.00
-3.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ares Commercial Real Estate Corporation (ACRE) has a negative trailing P/E of -300.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 17.1 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.33%, forward earnings yield 5.86%. PEG 0.42 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -300.7); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.33%).
  • Forward P/E 17.1 — analysts expect a return to profitability with estimated EPS of $0.30 for FY2026.
  • PEG Ratio 0.42 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -0.33% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5.86% as earnings recover.
  • Analyst consensus target $5.00 (-3.3% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 23/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
23/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ACRE

Valuation Multiples
P/E (TTM)-300.7
Forward P/E17.1
PEG Ratio0.42
Forward PEG0.42
P/B Ratio0.53
P/S Ratio4.86
EV/EBITDA32.1
Per Share Data
EPS (TTM)$-0.02
Forward EPS (Est.)$0.30
Book Value / Share$9.27
Revenue / Share$1.02
FCF / Share$0.38
Yields & Fair Value
Earnings Yield-0.33%
Forward Earnings Yield5.86%
Dividend Yield12.16%
SharesGrow IV$1.14 (-77.9%)
Analyst Target$5.00 (-3.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 9.7 0.53 0.93 8.66 7.52%
2017 12.1 -0.49 0.88 7.93 8.31%
2018 9.6 0.37 0.87 6.73 8.63%
2019 12.3 -2.76 1.06 5.87 8.27%
2020 18.0 -0.37 0.83 4.99 10.89%
2021 10.2 0.09 0.91 6.04 9.48%
2022 17.9 -0.30 0.71 4.88 13.50%
2023 -14.5 0.06 0.90 510.77 13.51%
2024 -9.2 0.82 0.59 3.65 18.60%
2025 -290.9 2.99 0.51 3.07 14.87%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.41 $45.11M $40.34M 89.4%
2017 $1.07 $46.35M $30.41M 65.6%
2018 $1.35 $55.28M $38.6M 69.8%
2019 $1.28 $77.26M $36.99M 47.9%
2020 $0.66 $78.69M $21.84M 27.8%
2021 $1.42 $102.07M $60.46M 59.2%
2022 $0.57 $109.05M $29.79M 27.3%
2023 $-0.72 $1.1M $-38.87M -3530.2%
2024 $-0.64 $-15.23M $-34.99M -
2025 $-0.02 $85.35M $-902K -1.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.30 $0.19 – $0.41 $47.68M $43.67M – $51.69M 3
2027 $0.61 $0.57 – $0.64 $60M $56.85M – $63.23M 2
2028 $0.60 $0.56 – $0.64 $62M $58.74M – $65.33M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message